Chemotherapy of malignant thymoma. Case report and review of the literature.

Abstract:

:The authors report the case of a patient with malignant thymoma unresponsive to combination chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone [CHOP] and cisplatin/VP-16) who subsequently achieved clinical response to continuous daily prednisone. A review of the literature indicates that prednisone and cisplatin are the most active agents in the treatment of malignant thymoma.

journal_name

Cancer

journal_title

Cancer

authors

Hu E,Levine J

doi

10.1002/1097-0142(19860315)57:6<1101::aid-cncr2820

subject

Has Abstract

pub_date

1986-03-15 00:00:00

pages

1101-4

issue

6

eissn

0008-543X

issn

1097-0142

journal_volume

57

pub_type

杂志文章

相关文献

CANCER文献大全
  • Local environmental influences on uveal melanoma: vitreous humor promotes uveal melanoma invasion, whereas the aqueous can be inhibitory.

    abstract:BACKGROUND:Uveal melanomas of the choroid and ciliary body are aggressive tumors causing the death of approximately 50% of patients. In contrast, iris melanomas only infrequently metastasize; why these differences exist is not known. The local environment can regulate cancer growth and development, and it is probable t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23358

    authors: Canovas D,Rennie IG,Nichols CE,Sisley K

    更新日期:2008-04-15 00:00:00

  • A Web-based communication aid for patients with cancer: the CONNECT Study.

    abstract:BACKGROUND:Cancer patients and their oncologists often report differing perceptions of consultation discussions and discordant expectations regarding treatment outcomes. CONNECT, a computer-based communication aid, was developed to improve communication between patients and oncologists. METHODS:CONNECT includes assess...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.27874

    authors: Meropol NJ,Egleston BL,Buzaglo JS,Balshem A,Benson AB 3rd,Cegala DJ,Cohen RB,Collins M,Diefenbach MA,Miller SM,Fleisher L,Millard JL,Ross EA,Schulman KA,Silver A,Slater E,Solarino N,Sulmasy DP,Trinastic J,Weinfurt K

    更新日期:2013-04-01 00:00:00

  • Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer.

    abstract:BACKGROUND:Many experienced oncologists have encountered patients with proven non-small cell lung cancer (NCLC) who received modest doses of palliative radiotherapy (RT) and who unexpectedly survived for > 5 years; some were apparently cured. We used a very large prospective database to estimate the frequency of this p...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21704

    authors: Mac Manus MP,Matthews JP,Wada M,Wirth A,Worotniuk V,Ball DL

    更新日期:2006-03-01 00:00:00

  • Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma.

    abstract:BACKGROUND:To the authors' knowledge, little is known to date regarding the prognostic relevance of measuring serum levels of vascular endothelial growth factor (VEGF), a potent stimulator of angiogenesis, in patients with colon carcinoma who undergo surgery. METHODS:Preoperative and postoperative VEGF serum levels we...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11911

    authors: De Vita F,Orditura M,Lieto E,Infusino S,Morgillo F,Martinelli E,Castellano P,Romano C,Ciardiello F,Catalano G,Pignatelli C,Galizia G

    更新日期:2004-01-15 00:00:00

  • T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature.

    abstract:BACKGROUND:To the authors' knowledge, there is no standard treatment for patients with T-cell large granular lymphocyte (LGL) leukemia. Available data are limited by patient numbers and coexisting pathologies. METHODS:The authors report on the use of immunosuppressants (cyclosporin A [CSA] and low-dose oral methotrexa...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.22032

    authors: Osuji N,Matutes E,Tjonnfjord G,Grech H,Del Giudice I,Wotherspoon A,Swansbury JG,Catovsky D

    更新日期:2006-08-01 00:00:00

  • Prognostic factors and outcome in bilateral Wilms' tumor.

    abstract::Twenty-one patients with bilateral Wilms' tumor are reviewed and the details of diagnosis, therapy, and survival presented. All patients had an abdominal mass at the time of diagnosis. Associated findings included hypertension, aniridia, and genitourinary anomalies. Favorable histologic features were found in all simu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19851115)56:10<2524::aid-cncr282

    authors: Asch MJ,Siegel S,White L,Fonkalsrud E,Hays D,Isaacs H

    更新日期:1985-11-15 00:00:00

  • Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients.

    abstract:BACKGROUND:To the authors' knowledge, the potential prognostic value of DNA ploidy in vulvar melanoma has not been evaluated in previous series. METHODS:Clinical data and follow-up information were retrieved from the hospital records of 75 patients treated from 1956 to 1987. Histopathologic specimens were reviewed for...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950101)75:1<72::aid-cncr282075

    authors: Scheistrøen M,Tropé C,Koern J,Pettersen EO,Abeler VM,Kristensen GB

    更新日期:1995-01-01 00:00:00

  • Cerebral metastases pathology after radiosurgery: a multicenter study.

    abstract:BACKGROUND:To the authors' knowledge, comprehensive human pathologic investigations that explore fundamental radiosurgical effects on metastatic brain tumors are sparse in the literature. The objective of this study was to analyze histopathologic findings in a set of clinically recurrent cerebral metastases after patie...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.21946

    authors: Szeifert GT,Atteberry DS,Kondziolka D,Levivier M,Lunsford LD

    更新日期:2006-06-15 00:00:00

  • The Akt/mammalian target of rapamycin pathway is activated and associated with adverse prognosis in soft tissue leiomyosarcomas.

    abstract:BACKGROUND:The Akt/mammalian target of rapamycin (mTOR) pathway mediates cell survival and proliferation and contributes to tumor progression. Soft tissue leiomyosarcoma continues to show poor prognosis, and little is known about its mechanisms of tumor progression. Here the authors investigated the significance of act...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26448

    authors: Setsu N,Yamamoto H,Kohashi K,Endo M,Matsuda S,Yokoyama R,Nishiyama K,Iwamoto Y,Dobashi Y,Oda Y

    更新日期:2012-03-15 00:00:00

  • Urinary pepsinogen I as a tumor marker of stomach cancer after total gastrectomy.

    abstract::The possibility that urinary pepsinogen I is a tumor marker of stomach cancer after total gastrectomy was examined. To decide the cutoff level of urinary pepsinogen I after total gastrectomy, urine samples from 15 patients who had undergone total gastrectomy for stomach cancer in the early or advanced stages and had b...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910815)68:4<906::aid-cncr28206

    authors: Yamaguchi T,Takahashi T,Yokota T,Kitamura K,Noguchi A,Kamiguchi M,Doi M,Ahn T,Sawai K,Yamane T

    更新日期:1991-08-15 00:00:00

  • Ultrastructural identification of a benign perineurial cell tumor.

    abstract::A solitary tumor which by light microscopy was calssified as a neurofibroma was found by electron microscopic study to be composed of parallel, elongate cells with collagen rich intervening matrix. The cells showed thin, polar cytoplasmic processes which extended long distances, frequent junctional complexes between c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197805)41:5<1823::aid-cncr282041

    authors: Lazarus SS,Trombetta LD

    更新日期:1978-05-01 00:00:00

  • Presentation and subsequent publication rates of phase I oncology clinical trials.

    abstract:BACKGROUND:Many trials submitted to scientific meetings are not reported in peer-reviewed journals. Results may vary substantially and the lack of final publication constitutes a form of reporting bias. The authors sought to determine the presentation and publication rates of Phase I trials submitted to a major oncolog...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21337

    authors: Camacho LH,Bacik J,Cheung A,Spriggs DR

    更新日期:2005-10-01 00:00:00

  • Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.

    abstract:BACKGROUND:Because of the structural and biochemical similarities between the antitumor p53 and p73 proteins, the authors hypothesized that individuals who carry high-risk genotypes of p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms have a higher risk of developing second primary malignancy (SPM) after index squamous...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26222

    authors: Zhang Y,Sturgis EM,Huang Z,Zafereo ME,Wei Q,Li G

    更新日期:2012-01-15 00:00:00

  • Prognostic impact of morphometric nuclear grade of endometrial carcinoma.

    abstract:BACKGROUND:The identification of high risk patients with endometrial carcinoma is considered essential for individualized therapy to improve prognosis and avoid overtreatment. The goal of the current study was to investigate the prognostic value of nuclear morphometry, particularly for patients with localized endometri...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Salvesen HB,Iversen OE,Akslen LA

    更新日期:1998-09-01 00:00:00

  • Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.

    abstract:BACKGROUND:The objective of this study was to investigate the patterns of recurrence, various prognostic factors, and the role of radioiodine in the treatment of patients with follicular thyroid carcinoma (FTC). METHODS:The clinical outcomes of 215 patients with FTC who were treated at a single institution were analyz...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10683

    authors: Chow SM,Law SC,Mendenhall WM,Au SK,Yau S,Yuen KT,Law CC,Lau WH

    更新日期:2002-08-01 00:00:00

  • Active immunotherapy of human solid tumor with autologous cells treated with cholesteryl hemisuccinate. A Phase I study.

    abstract::A marked increase in specific immunogenicity of tumor cells is induced upon incorporation of cholesteryl hemisuccinate (CHS) into the cell membrane, which presumably promotes the expression of latent tumor-associated antigens. Immunotherapy with CHS-treated and irradiated tumor cells as vaccine was found to be very ef...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19860801)58:3<650::aid-cncr28205

    authors: Skornick YG,Rong GH,Sindelar WF,Richert L,Klausner JM,Rozin RR,Shinitzky M

    更新日期:1986-08-01 00:00:00

  • Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases.

    abstract:BACKGROUND:Papanicolaou smear sensitivity for cervical adenocarcinoma (CVCA) is not well established. Also uncertain are the relative contributions to falsely negative diagnoses of sampling, screening, and interpretive errors. METHODS:Papanicolaou smears were identified from all patients at our institutions with biops...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Krane JF,Granter SR,Trask CE,Hogan CL,Lee KR

    更新日期:2001-02-25 00:00:00

  • A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer.

    abstract:BACKGROUND:Sunitinib has replaced interferon (IFN) as a first-line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. METHODS:Data were collected on all patients i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24051

    authors: Heng DY,Chi KN,Murray N,Jin T,Garcia JA,Bukowski RM,Rini BI,Kollmannsberger C

    更新日期:2009-02-15 00:00:00

  • Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

    abstract:BACKGROUND:Cyclin D1 expression has been reported in a subset of patients with diffuse large B-cell leukemia (DLBCL), but studies have been few and generally small, and they have demonstrated no obvious clinical implications attributable to cyclin D1 expression. METHODS:The authors reviewed 1435 patients who were diag...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28664

    authors: Ok CY,Xu-Monette ZY,Tzankov A,O'Malley DP,Montes-Moreno S,Visco C,Møller MB,Dybkaer K,Orazi A,Zu Y,Bhagat G,Richards KL,Hsi ED,Han van Krieken J,Ponzoni M,Farnen JP,Piris MA,Winter JN,Medeiros LJ,Young KH

    更新日期:2014-06-15 00:00:00

  • Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.

    abstract:BACKGROUND:After the introduction of a mammography screening program, the incidence of late-stage breast cancer is expected to decrease. The objective of the current study was to evaluate variations in the total incidence of breast cancer and in the incidence of breast cancers with a pathologic tumor (pT) classificatio...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28014

    authors: Foca F,Mancini S,Bucchi L,Puliti D,Zappa M,Naldoni C,Falcini F,Gambino ML,Piffer S,Sanoja Gonzalez ME,Stracci F,Zorzi M,Paci E,IMPACT Working Group.

    更新日期:2013-06-01 00:00:00

  • HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

    abstract:BACKGROUND:Chronic myeloid leukemia (CML) may progress to blast phase (BP) at the rate of 1% to 1.5% per year. With the use of single-agent tyrosine kinase inhibitors, median overall survival ranges between 7 and 11 months. METHODS:The outcome was analyzed for 42 patients with lymphoid BP-CML who were treated with hyp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28433

    authors: Strati P,Kantarjian H,Thomas D,O'Brien S,Konoplev S,Jorgensen JL,Luthra R,Abruzzo L,Jabbour E,Quintas-Cardama A,Borthakur G,Faderl S,Ravandi F,Cortes J

    更新日期:2014-02-01 00:00:00

  • Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features: A phase II Cancer and Leukemia Group B Study (9051).

    abstract:BACKGROUND:The aim of this study was to evaluate a regimen of sequential chemotherapy and radiotherapy for patients with Hodgkin disease. METHODS:The Cancer and Leukemia Group B conducted a Phase II study of three cycles of etoposide, vinblastine, and doxorubicin (EVA) chemotherapy followed by subtotal lymph node radi...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/(sici)1097-0142(19991015)86:8<1590::aid-cn

    authors: Wasserman TH,Petroni GR,Millard FE,Chung CT,Barcos M,Johnson JL,Canellos GP,Peterson BA

    更新日期:1999-10-15 00:00:00

  • Closing the divide: diverse populations and cancer survivorship.

    abstract::Currently, there is a "divide" between cancer survivorship initiatives and minority participation. The level of participation is nearly nonexistent in many cancer support and control initiatives. Cancer survivorship resources that facilitate access to treatment, psychosocial interventions, clinical trials, and researc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21251

    authors: Guidry JJ,Torrence W,Herbelin S

    更新日期:2005-12-01 00:00:00

  • Renal disease after mitomycin C therapy.

    abstract::Fourteen patients with adenocarcinoma of the gastrointestinal tract and pancreas treated with mitomycin C(MMC) and 5-fluorouracil (5-FU) had renal impairment 6-11 months from the beginning of MMC therapy. Two clinical entities were recognized: an acute fulminating renal failure that was rapidly fatal and a chronic slo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811215)48:12<2583::aid-cncr282

    authors: Hanna WT,Krauss S,Regester RF,Murphy WM

    更新日期:1981-12-15 00:00:00

  • Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors.

    abstract:BACKGROUND:The frequency of mutant p53 in bone marrow metastases of patients with carcinoma of the prostate (CaP) and in matched sets of metastatic and primary lesions from the same patients was investigated. The data were examined in relation to prior treatment with androgen ablation (AA) therapy and were compared wit...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Meyers FJ,Gumerlock PH,Chi SG,Borchers H,Deitch AD,deVere White RW

    更新日期:1998-12-15 00:00:00

  • Medical adrenalectomy in patients with advanced breast cancer.

    abstract::Medical adrenalectomy, consisting of aminoglutethimide plus either dexamethasone or hydrocortisone, was administered to 53 women with advanced breast cancer. Sixteen (30%) patients had an objective response, five patients had stabilization of disease, 26 patients demonstrated progression of disease, two patients did n...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820315)49:6<1145::aid-cncr2820

    authors: Horsley JS 3rd,Newsome HH,Brown PW,Neifeld JP,Terz JJ,Lawrence W Jr

    更新日期:1982-03-15 00:00:00

  • Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status.

    abstract:BACKGROUND:Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) tests are commonly used to assess human epidermal growth factor 2 (HER2) status of tumors in patients with breast cancer. This analysis evaluates the likely cost-effectiveness of expanded retesting to assess HER2 tumor status in women w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28196

    authors: Garrison LP Jr,Lalla D,Brammer M,Babigumira JB,Wang B,Perez EA

    更新日期:2013-09-01 00:00:00

  • Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase.

    abstract::Exposure of tumor cells to reduced folates before or with the fluoropyrimidines, 5-fluorouracil or 5-fluoro-2'deoxyuridine, results in a substantial increase in the activity of these drugs. Available evidence suggests that the mechanism of this synergism is a kinetic stabilization of complex formed between thymidylate...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19890315)63:6+<1008::aid-cncr282

    authors: Morgan RG

    更新日期:1989-03-15 00:00:00

  • Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer.

    abstract::To assess the efficacy of performing both computed tomography (CT) of the thorax and upper abdomen and whole-body gallium scintigraphy for staging lung cancer, the results of each test were compared with those obtained by chest radiography and clinical examination in 100 patients. Clinical efficacy was defined in term...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19891001)64:7<1404::aid-cncr2820

    authors: MacMahon H,Scott W,Ryan JW,Montner SM,Little AG,Hoffman PC,Ferguson MK,Golomb HM

    更新日期:1989-10-01 00:00:00

  • Intensity-modulated radiation therapy use in the U.S., 2004.

    abstract:BACKGROUND:Intensity-modulated radiation therapy (IMRT) is a novel approach to the planning and delivery of radiation therapy. The prevalence of IMRT use among radiation oncologists in the U.S. appears to be increasing, despite limited data evaluating its risks and benefits. METHODS:A random sample of radiation oncolo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21284

    authors: Mell LK,Mehrotra AK,Mundt AJ

    更新日期:2005-09-15 00:00:00